|

A Cardiac Disease Quality of Life Study

RECRUITINGSponsored by The Cleveland Clinic
Actively Recruiting
SponsorThe Cleveland Clinic
Started2019-08-26
Est. completion2026-12
Eligibility
Age18 Years – 70 Years
Locations1 site

Summary

A prospective, longitudinal, non-comparator, non-randomized observational cohort study to assess the quality of life in adult patients affected by hypertrophic cardiomyopathy and thoracic aortic dilatations who are not amenable to surgery, as well as those affected radiation-induced cardiac disease caused by radiation therapy.

Eligibility

Age: 18 Years – 70 Years
Inclusion Criteria:

* Patients aged 18-70 at time of consent with a confirmed diagnosis of HCM, TAD, and/or RIHD being seen at CC Main Campus for a comprehensive clinical cardiac evaluation (i.e. physician, surgeon, nurse practitioner, geneticist, testing, imaging, etc) to define treatment plan for either diagnosis as per Cleveland Clinic provider.
* Patient or an individual in their social support network has the equipment (phone, computer, tablet) and internet connection to complete the emailed follow-up questionnaires.

Exclusion Criteria:

* Previously had surgery or plans to have surgery (full/mini sternotomy or endovascular) in the next nine months for HCM or TAD.
* Inability or unwillingness to comply with study requirements in the opinion of the investigator.
* Inability to provide informed consent.

Conditions5

Heart DiseaseHeart Disease Caused by Ionising RadiationHypertrophic Obstructive CardiomyopathyQuality of LifeThoracic Aortic Dilatation

Locations1 site

Cleveland Clinic
Cleveland, Ohio, 44195
Milind Desai, MD216 445-5250Desaim2@ccf.org

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.